logo_hcam

Revista Médica Científica CAMbios

Periodicidad semestral: flujo continuo.

ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)

Ver PDF (Spanish)
Ver HTML (Spanish)

Keywords

Hepatitis B
Serology
Antigen
Antibody Formation
Prevalence
Observational Study

How to Cite

1.
Prevalence of post-vaccine antibodies against surface antigen of Hepatitis B Virus. Cambios rev. méd. [Internet]. 2018 Dec. 28 [cited 2025 Oct. 8];17(2):52-8. Available from: https://revistahcam.iess.gob.ec/index.php/cambios/article/view/304

Abstract

INTRODUCTION. Biological risks must be treated in a special way; how to take into account the amount of Antibodies Anti Hbs Hepatitis B according to the number of vaccines administered and the workplace. OBJECTIVE. To determine the prevalence of postvaccine anti-antigen antibodies to Hepatitis B virus surface, in health workers, according to the number of doses received. MATERIALS AND METHODS. Retrospective study of the prevalence of post-vacunal antibodies against antigen. of surface of the Hepatitis B virus, in the health personnel according to the number of vaccines, in the Hospital of Specialties Carlos Andrade Marín, in the period between March and October of 2017, analyzed in the Computer System AS 400. RESULTS. Female sex predominated. The age was 31,88% (32; 414), (30 and 40 years of age), as the majority area was the Surgery Service with 42,51% (43; 414) of the total that generated more antibodies at 100UI / ml and were considered seroprotected. In workers who were not given the standard dosage levels were generated lower than those that culminated this dosage, CONCLUSION. The prevalence of serum levels of antibodies against surface antigen was determined, was established according to the number of doses, vaccination was the main source of generation of antibodies against surface antigen or anti - Hbs

Ver PDF (Spanish)
Ver HTML (Spanish)

 

The authors who publish in this journal accept the following conditions:

1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.

2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.